Holowesko Partners Ltd. Makes New Investment in Kenvue Inc. $KVUE

Holowesko Partners Ltd. acquired a new position in shares of Kenvue Inc. (NYSE:KVUE) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 358,000 shares of the company’s stock, valued at approximately $6,176,000. Kenvue makes up approximately 2.1% of Holowesko Partners Ltd.’s investment portfolio, making the stock its 15th biggest holding.

Several other large investors have also recently bought and sold shares of the company. Physician Wealth Advisors Inc. raised its position in shares of Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after acquiring an additional 618 shares during the last quarter. Elyxium Wealth LLC bought a new stake in shares of Kenvue during the 4th quarter valued at $26,000. SBI Securities Co. Ltd. raised its position in shares of Kenvue by 82.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock valued at $39,000 after acquiring an additional 1,027 shares during the last quarter. Atlantic Union Bankshares Corp raised its position in shares of Kenvue by 184.1% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 2,619 shares of the company’s stock valued at $43,000 after acquiring an additional 1,697 shares during the last quarter. Finally, Leonteq Securities AG bought a new stake in shares of Kenvue during the 4th quarter valued at $45,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

KVUE has been the subject of several recent research reports. Citigroup dropped their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 8th. Barclays dropped their target price on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Argus upgraded shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Finally, Canaccord Genuity Group upped their target price on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Wednesday, February 18th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $19.33.

Insider Buying and Selling

In related news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 1.59% of the company’s stock.

Kenvue Stock Performance

Shares of Kenvue stock opened at $17.72 on Monday. The company has a market capitalization of $34.01 billion, a PE ratio of 20.84, a PEG ratio of 1.34 and a beta of 0.54. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $22.87. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock’s fifty day simple moving average is $17.37 and its 200 day simple moving average is $17.48.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.27 by $0.05. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm’s revenue was up 4.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.24 EPS. On average, research analysts predict that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were paid a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.7%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.